Copyright
©The Author(s) 2020.
World J Transplant. May 29, 2020; 10(5): 104-116
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.104
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.104
Figure 2 Anatomical and histopathological differences between bronchiolitis obliterans syndrome and restrictive allograft syndrome based on immune responses in transplanted lungs.
BOS: Bronchiolitis obliterans syndrome; CCL: CC chemokine ligand; CXCL: CXC chemokine ligand; DC: Dendritic cell; HEV: High endothelial venules; PDGF: Platelet-derived growth factor; PNAd: Peripheral node addressin; RAS: Restrictive allograft syndrome; TGF-β: Transforming growth factor beta.
- Citation: Yoshiyasu N, Sato M. Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome. World J Transplant 2020; 10(5): 104-116
- URL: https://www.wjgnet.com/2220-3230/full/v10/i5/104.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i5.104